Mednet Logo

When do you consider changing a patient's levothyroxine dose during hospitalization due to abnormal TFTs, but without clinical evidence of thyrotoxicosis or hypothyroidism?

2 Answers
Mednet Member
Mednet MemberInvited Expert
General Internal Medicine · University of Chicago
Answered on

Thank you for your question. I think this is something we commonly get in the hospital, and we often overreact to it. This was a "Things We Do For No Reason" some time back, and I think they outline the issues well.

When people are acutely ill, TSH testing is unreliable. The times when TSH testing is...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Hospital Medicine · University of California San Francisco
Answered on

In general, unless I can attribute some aspect of their acute illness to the abnormality and/or it's at the true extremes, I do not make changes. I always make sure that it's ordered for follow-up testing in 3-4 weeks and that PCP is aware of the need to follow up.

Join for free or sign in to see the full answer